Trump's week in review: Stops gain-of-function research, opens 'MyGender' dolls investigation

4. Trump admin. establishes new policy seeking to stop gain-of-function research

In a statement Tuesday, the U.S. Department of Health and Human Services announced the release of the United States Government Policy for Stopping High-Risk Life Sciences Research.

The policy specifically singles out “dangerous gain-of-function (DGOF) research” and “international research of concern” as types of research that “should not be undertaken domestically or abroad under any circumstance.”

As explained in the document, gain-of-function research “enhances a property or properties of a biological agent in ways that make it more dangerous” and “could result in significant negative societal consequences.”

The concept of gain-of-function research has gained increased attention and scrutiny following the COVID-19 pandemic. Federal funding for “dangerous gain-of-function research” is prohibited under the new policy.

As for “international research of concern,” federal funding for any life science research taking place in countries of concern or by institutions of concern or individuals of concern is prohibited. 

Ryan Foley is a reporter for The Christian Post. He can be reached at: ryan.foley@christianpost.com

Was this article helpful?

Become a CP Insider.
Help keep The Christian Post free for everyone.

The truth has a cost, and Insiders help carry it.
A dollar from an Insider comes with no strings attached. It keeps our reporters on the story, keeps our journalism open to everyone, and keeps every editorial decision in the newsroom, where it belongs.

Become a CP Insider and choose the amount you want to pay. You can change, pause or cancel anytime. As a thank-you, you’ll get:

  • The Insider Newsletter, a members-only monthly letter from our newsroom

  • Ad-free reading across christianpost.com


From as low as $8.25/month
Prefer to give once?

We’re sorry to hear that.

Hope you’ll give us another try and check out some other articles.
Return to homepage.

Most Popular